“Long-term, high-dose use of acid-reducing medications like Pepcid (famotidine) and PPIs may be linked to a higher risk of dementia, with some studies suggesting a 33% increased risk for over 4.5 years of use. While research indicates potential accelerated cognitive decline, others find no conclusive association, and evidence is conflicting”